Zydus Pharmaceuticals (USA) Inc.

Zydus Pharmaceuticals (USA) Inc. is a globally integrated generic pharmaceutical company with a focus on providing high service, quality and affordable products. Our leadership, which has over 40 years of US generic market experience, understands our customer’s business which allows Zydus Pharmaceuticals the ability to provide unique models to help drive their success. Though a new company in the US market, our parent Zydus Cadila has a large presence in the global markets, including relationships with many top tier international pharmaceutical companies. Based on a manufacturing and development history that spans over 50 years, our experience and knowledge affords us the ability to have one of the largest and most aggressive DMF and finished product pipelines in the industry.
Over the next three years we will be filing on average two additional products and DMFs per month. Through 2005 we will exceed that goal by filing 30 products and 28 DMFs. We’re ready now to support that growth with the largest, state-of-the-art, cGMP, FDA approved formulation plant in India boasting a capacity near 12 billion units. We also have two FDA approved API plants with capacities exceeding 280 metric tons. Our sustained release technology and ability to manufacture tablet, capsule, soft gel, sterile liquids, injectables, inhalers, and trans-dermal patch dosage forms allows us to target even the most difficult of products. Once manufactured, our packaging area is equipped to handle special customer requests such as bulk, unit-of-use, blister, and consumer product packaging.

Contact Details: 508 Carnegie CenterSuite 101 Princeton New Jersey 08540 United States of America Tel: (609)275-5125 Fax: (609)275-0499 Email: sales@zydususa.com WWW: www.zydususa.com/

Loading...

Press Releases on Zydus Pharmaceuticals (USA) Inc.:
Zydus Pharmaceuticals (USA) Inc. Announces FDA Final Approval for the Generic Version of Topamax(R) Tablets	27th March, 2009	Zydus Pharmaceuticals (USA) Inc.	PRINCETON, N.J., March 27 /PRNewswire/ -- Zydus Pharmaceuticals announced today that it has received final approval from the U.S. Food and Drug Administration (FDA) for its Abbreviated New Drug

Contact BioPortfolio for a quote for a customised Excel verision of BioCorporate or BioEmail databases.

This page has been viewed 1756 times since April 2007, the link to the organisation's website has been followed 235 times

Recent Search Terms used to find this page: find zydus pharmaceutic mfg | zydus pharmaceuticals | zydus medica history products | zydus | zydus | zydus | zydus inhalers | zydus pharmaceuticals | zydus pharmaceuticals | Zydus Pharmaceuticals | .

Search for more companies in Princeton

Search for more companies in New Jersey

This site uses Thumbshots previews, resources from the NCBI applied. Maps are centred on zip/postcodes and should not be relied upon for exact building locations. Some information on this page has been collected automatically and may not have been verified.
BioPortfolio search results for Zydus Pharmaceuticals (USA) Inc.